Trastuzumab upregulates expression of HLA-ABC and T cell costimulatory molecules through engagement of natural killer cells and stimulation of IFNγ secretion

It is increasingly recognized that trastuzumab, an antibody approved for treating human epidermal growth factor receptor 2 (HER2)-overexpressing breast cancer, exerts some of its antitumor effects through enhanced T cell responses. Full activation of CD8(+) T cells requires both expression of major...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncoimmunology
Main Authors: Chaganty, Bharat K. R., Lu, Yang, Qiu, Songbo, Somanchi, Srinivas S., Lee, Dean A., Fan, Zhen
Formato: Artigo
Idioma:Inglês
Publicado em: Taylor & Francis 2015
Assuntos:
Original Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4839349/
https://ncbi.nlm.nih.gov/pubmed/27141382
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2015.1100790
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados